Jones Financial Companies
CLYM icon

Jones Financial Companies’s Climb Bio CLYM Stock Holding History

Jones Financial Companies’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48K Hold
266
– – ﹤0.01% 4254
2026
Q1 		$1.87K Buy
+266
New +$1.53K ﹤0.01% 4170

Other funds holding CLYM

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jones Financial Companies's CLYM Position: Q2 2026 in Review

Jones Financial Companies held its Climb Bio (CLYM) position steady in Q2 2026 at 266 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

Jones Financial Companies first reported a position in CLYM in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Jones Financial Companies held 266 shares of Climb Bio worth $3.48K as of Q2 2026.
  • Jones Financial Companies left its Climb Bio share count unchanged in Q2 2026.
  • Climb Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4254 holding.
  • Jones Financial Companies first reported a position in Climb Bio in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.